If you are really a shareholder you will know that the 4 trials are scheduled to cost approx $3mn. 90% of this money has been put up by Cannvalate and the other 10% is easily affordable by IHL. So there is no reason for the IHL to pursue shoddy trials to save money just to promote some newsflow as you claim.
You seem to be intent on spreading false innuendo and arguing with other HC posters which is quite an achievement for someone with only 3 posts on the HC site.
Luckily there is an ignore option on HC
EB
- Forums
- ASX - By Stock
- Ann: Commencement of Phase 2a Sleep Apnoea Clinical Trial
If you are really a shareholder you will know that the 4 trials...
-
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online